Review Series - April 12, 2018

Update on Hodgkin Lymphoma

Introduced with an editorial by Blood Associate Editor Laurie H. Sehn, the articles in this series of reviews on Hodgkin lymphoma explore advances in biological insights that have led to the identification of novel targets for drug development and enabled more accurate prognostication. They also examine optimization of various therapeutic strategies for early-stage, advanced-stage, and relapsed disease.

Laurie H. Sehn, MDCM, MPH, shares highlights of this review series.


Review Series Articles: